#coagulation analyzer

Fison Automatic Coagulation Analyzer performs 140 tests/hour with fast, consistent results. Tilting the reagent position reduces waste, and LED lighting with alarms enhances visibility and safety. Alerts for low cleaning fluid, waste overflow, and emergency sample processing ensure smooth lab operation.

The global coagulation analyzer market is poised for significant growth, driven by a combination of factors that are transforming the healthcare landscape. With an estimated value of USD 4.72 billion in 2024, the market is expected to expand at a compound annual growth rate (CAGR) of 5.2% from 2025 to 2030.

The hemostasis and coagulation analyzer market primarily includes point-of-care hemostasis testing analyzers and clinical laboratory hemostasis testing analyzers that are used to test various blood coagulation parameters and processes for diagnostic and treatment monitoring purposes. These analyzers measure parameters like coagulation factors, fibrinogen levels, D-dimer and prothrombin time and help detect bleeding disorders, determine therapy, and monitor anticoagulant drug therapy among others. The advantages of these analyzers are that they provide fast and automated testing methods for hemostasis and coagulation parameters as compared to traditional manual methods. Considering the rising lifestyle and chronic diseases like cardiovascular diseases and cancer which require coagulation monitoring, there is a growing need for these analyzers in hospitals, clinics and diagnostic centers.

The Global Hemostasis/ Coagulation Analyzer Market  is estimated to be valued at US$ 6.47 Bn  in 2024 and is expected to exhibit a CAGR of 5.8% over the forecast period 2024 to 2031. Key Takeaways Key players operating in the Hemostasis/ Coagulation Analyzer Market Growth are Horiba Medical, Siemens Healthineers AG, Agappe Diagnostics Ltd, NIHON KOHDEN CORPORATION, Sysmex Corporation, F. Hoffmann-La Roche Ltd, Stago Group, Maccura Biotechnology Co., Ltd., Thermo Fisher Scientific Inc., Haemonetics Corporation, Genrui Biotech Co., Ltd., BIOLABO S.A.S, Erba Mannheim, Sclavo Diagnostics International, and Helena Laboratories Corporation. Second paragraph is talking about the growing demand in market and third paragraph is talking about global expansion of market. The global hemostasis and coagulation analyzer market is expected to witness significant growth over the forecast period driven by the steadily increasing global incidence of chronic diseases such as cardiovascular diseases, cancer, diabetes as well as rising demand for point-of-care testing. Coagulation disorders occur frequently in cancer, and monitoring of coagulation parameters is vital during cancer diagnosis and treatment which will boost the demand for these analyzers. Furthermore, technological advancements leading to the development of advanced rapid point-of-care testing analyzers will augment the adoption across healthcare settings. Geographically, North America is anticipated to dominate the global market over the forecast years owing to increasing healthcare expenditure, availability of advanced hemostasis testing products, and presence of leading market players in the region. However, the Asia Pacific region is projected to exhibit the highest growth rate owing to improving access to diagnostics, increasing healthcare spending, rising patient pool of chronic diseases in counties like China and India. Product launches and expansions into emerging markets will further aid in the global expansion of key hemostasis and coagulation analyzer companies.

Microlab offers a state-of-the-art coagulation analyzer designed to meet the needs of modern medical laboratories. Our coagulation analyzer provides accurate and rapid testing for various coagulation parameters, essential for diagnosing and monitoring conditions such as hemophilia, thrombosis, and other coagulation disorders.

With advanced technology and intuitive interfaces, our analyzer ensures precise results with minimal operator intervention, enhancing workflow efficiency and reducing turnaround time.

Visit for more info : https://www.microlab.in/coagulation-analyzer.html

Address: 3, Akshay Appartment, Behind Popular House, Ashram Road, Ahmedabad: 380009, Gujarat, India.

Mail: [email protected]

The Microlab Coagulation Analyzer is a cutting-edge medical device designed to assess and analyze blood coagulation parameters efficiently and accurately. This sophisticated instrument is a vital tool in clinical laboratories, offering precise measurements to aid healthcare professionals in diagnosing and monitoring various medical conditions related to blood clotting.

Equipped with advanced technology, the Coagulation Analyzer by Microlab utilizes a variety of test methodologies to evaluate clotting factors, including but not limited to prothrombin time (PT), activated partial thromboplastin time (aPTT), and international normalized ratio (INR). These parameters are crucial in assessing the coagulation cascade and identifying potential abnormalities in the blood clotting process.

Visit for more info : https://www.microlab.in/coagulation-analyzer.html

Address : 3, Akshay Appartment, Behind Popular House, Ashram Road, Ahmedabad: 380009, Gujarat, India.

Mail : [email protected]

Coagulation Analyzers ideal for all clotting assays hold a high sample capacity with a variance for testing channels. It provides precised results with low sampling consumption. Internal thermal printer for printing of data’s for end user convenience.

https://href.li/?https://www.zimed.com/coagulation-analyzers